AFM
ELOX

Anson Funds Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Anson Funds Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,841
Closed -$391K – 467
2021
Q4 		$391K Buy
+13,841
New +$603K 0.04% 260

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Anson Funds Management's ELOX Position: Q1 2022 in Review

Anson Funds Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2022, closing a stake of 13,841 shares — an estimated $391K sold.

Anson Funds Management first reported a position in ELOX in Q4 2021 and held it in 1 quarter. The position peaked at $391K in Q4 2021. 35 funds tracked by Wall St. Rank hold ELOX as of Q1 2022.

  • Anson Funds Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Anson Funds Management sold 13,841 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $391K.
  • Anson Funds Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Anson Funds Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $391K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.